Albarico, Victoria .
HRN: 28-04-82 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/05/2025
CLINDAMYCIN 150MG/ML, 4ML (AMP)
11/05/2025
11/12/2025
IV
600
Q6h
Infected Breast Mass
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes